Revenio Group company profile

REG1V · Nasdaq Helsinki · EUR

Compare Revenio Group
€9.04Change from previous close: −1.74%Absolute change: −€0.16

Close · November 20, 2026

Company profile

Revenio Group has 765 employees and is headquartered in Vantaa, Finland.

The iCare tonometer range, including the iCare HOME2 for measuring eye pressure at home and the TONOVET models used in surgical settings and by veterinarians, forms the core of the product line of Revenio Group Oyj. Alongside these devices the company sells imaging equipment such as iCare EIDON and iCare COMPASS, and software including iCare ILLUME, which uses artificial intelligence to screen for early signs of eye disease, iCare CLINIC for long-term pressure records, and the Oculo platform for telehealth and remote patient monitoring. Its customers include ophthalmologists, veterinarians and other clinical staff, and it sells in Finland, the United States and other countries.

In the fiscal year ended December 2025, Revenio Group Oyj reported revenue of EUR 109.8 million, up 5.8% from the previous year, and net income of EUR 17.4 million. Founded in 2001, the company had 765 employees and is headquartered in Vantaa, Finland.

Company facts

Industry
Medical Devices
Country
Finland
Headquarters
Härkähaankuja 7, 01730, Vantaa
Employees
765
Chief executive
Jouni Toijala
Founded
2001
Fiscal year
January - December
Listing
REG1V · Nasdaq Helsinki
Currency
EUR
ISIN
FI0009010912

Revenio Group and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
Revenio GroupREG1VFinland$428.87M76514.1%25.1
Synektik Spólka AkcyjnaSNTPoland$647.15M23123.3%15.9
El.En.ELNItaly$1.44B1,45914.7%20.7
ChemoMetecCHEMMDenmark$1.75B17449.1%59.9
ElektaEKTA.BSweden$2.27B3,9969.2%—
Medacta GroupMOVESwitzerland$2.41B2,27315.2%27.7

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare Revenio Group with its competitors